共 21 条
- [21] Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma (vol 150, pg 200, 2010) [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) : 111 - 111